Publication | Closed Access
EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation
148
Citations
46
References
2014
Year
Hematological MalignancyLymphoid NeoplasiaMedicineImmunologyCancer Cell BiologyPathologyCancer TreatmentOncologyH3k27 MonomethylationCancer ResearchEzh2 Inhibitor EfficacyTumor BiologyLymphoma Does
| Year | Citations | |
|---|---|---|
Page 1
Page 1